PA
EVH icon

Parallel Advisors’s Evolent Health EVH Stock Holding History

Parallel Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.85K Buy
1,688
+493
+41% +$1.56K ﹤0.01% 3131
2025
Q4 		$4.78K Sell
1,195
-2,200
-65% -$12.2K ﹤0.01% 2860
2025
Q3 		$28.7K Sell
3,395
-92
-3% -$893 ﹤0.01% 2077
2025
Q2 		$39.3K Buy
3,487
+1,577
+83% +$14.5K ﹤0.01% 1861
2025
Q1 		$18.1K Buy
1,910
+1,185
+163% +$12K ﹤0.01% 2191
2024
Q4 		$8.16K Buy
725
+40
+6% +$703 ﹤0.01% 2480
2024
Q3 		$19.4K Sell
685
-9
-1% -$232 ﹤0.01% 2116
2024
Q2 		$13.3K Buy
694
+179
+35% +$4.57K ﹤0.01% 2201
2024
Q1 		$16.9K Sell
515
-16
-3% -$511 ﹤0.01% 2066
2023
Q4 		$17.5K Buy
531
+515
+3,219% +$14.6K ﹤0.01% 2018
2023
Q3 		$436 Sell
16
-6
-27% -$167 ﹤0.01% 3130
2023
Q2 		$667 Sell
22
-17
-44% -$550 ﹤0.01% 3035
2023
Q1 		$1.27K Sell
39
-74
-65% -$2.34K ﹤0.01% 2900
2022
Q4 		$3.17K Buy
113
+75
+197% +$2.15K ﹤0.01% 2504
2022
Q3 		$1K Sell
38
-18
-32% -$634 ﹤0.01% 2894
2022
Q2 		$2K Buy
56
+19
+51% +$554 ﹤0.01% 2565
2022
Q1 		$1K Sell
37
-51
-58% -$1.33K ﹤0.01% 2732
2021
Q4 		$2K Hold
88
– – ﹤0.01% 2685
2021
Q3 		$3K Hold
88
– – ﹤0.01% 2557
2021
Q2 		$2K Buy
88
+51
+138% +$1.02K ﹤0.01% 2547
2021
Q1 		$1K Buy
+37
New +$704 ﹤0.01% 2607
2020
Q2 		– Sell
-156
Closed – – 2516
2020
Q1 		$0 Sell
156
-224
-59% -$2K ﹤0.01% 2450
2019
Q4 		$3K Hold
380
– – ﹤0.01% 2096
2019
Q3 		$3K Buy
+380
New +$2.73K ﹤0.01% 2047
2019
Q1 		– Sell
-23
Closed – – 2311
2018
Q4 		$0 Buy
+23
New +$532 ﹤0.01% 2157

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallel Advisors's EVH Position: Q1 2026 in Review

Parallel Advisors increased its Evolent Health (EVH) stake by 41% in Q1 2026, buying an estimated $1.56K and bringing the position to 1,688 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3131.

Parallel Advisors first reported a position in EVH in Q4 2018 and has held it in 25 quarters since. The position peaked at $39.3K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Parallel Advisors held 1,688 shares of Evolent Health worth $3.85K as of Q1 2026.
  • Parallel Advisors bought 493 Evolent Health shares in Q1 2026, an estimated $1.56K.
  • Evolent Health made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3131 holding.
  • Parallel Advisors first reported a position in Evolent Health in Q4 2018 and has held it in 25 quarters since.
  • Parallel Advisors's Evolent Health position peaked at $39.3K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.